
Thermo Fisher Scientific - Largest Companies by Marketcap, Revenue, Net Income and Employees
Top Corporates Hub
Thermo Fisher Scientific
About
Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
- Sector: Health Technology
- Industry: Medical Specialties
- Headquarters:
Latest News
-
Sodium Perborate Company Evaluation Report 2025 | Thermo Fisher, Merck KGaA, and Evonik Treibacher Lead with Strategic Expansions, Strong Distribution, and Eco-Friendly Innovation
01.08.2025 -
North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers
29.07.2025 -
CFOs On the Move: Week ending July 25
25.07.2025 -
Thermo Fisher Scientific’s Chief Financial Officer, Stephen Williamson, to Retire in Early 2026
23.07.2025 -
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Amid US-Japan Deal
23.07.2025